NEWS26 April 2017
All MRS websites use cookies to help us improve our services. Any data collected is anonymised. If you continue using this site without accepting cookies you may experience some performance issues. Read about our cookies here.
All MRS websites use cookies to help us improve our services. Any data collected is anonymised. If you continue using this site without accepting cookies you may experience some performance issues. Read about our cookies here.
CHINA – Ipsos Healthcare has extended its syndicated psoriasis and IBD therapy monitors into China and will relaunch Lupus therapy monitor to meet client demand.
The new Chinese autoimmune studies, part of Ipsos’ syndicated global therapy monitor portfolio, will incorporate real patient record data with doctors’ perceptions to analyse the market landscape, market shares, reasons behind treatment trends and potential impact of products in development.
It will complement Ipsos Healthcare’s existing real world evidence offer in China, which covers oncology, diabetes, cardiovascular, respiratory and virology diseases.
Subscribers will get an in-depth analysis of the various factors shaping treatment choice in these indications, including drivers for and barriers to the uptake of biologics.
Pieter De Richter, regional head of APAC syndicated at Ipsos Healthcare, said: “The uptake of biologics for the treatment of autoimmune diseases has been slower in China than in established markets such as the US and Europe. However, the large number of patients suffering from these often debilitating conditions, linked to continuous improvements in reimbursement cover and access, present a huge opportunity for pharma companies offering effective and well-tolerated therapies.”
Newsletter
Sign up for the latest news and opinion.
You will be asked to create an account which also gives you free access to premium Impact content.
Media evaluation firm Comscore has increased its revenue in the second quarter but has made a net loss of $44.9m, a… https://t.co/rAHZYxiapz
RT @ImpactMRS: Marginalised groups are asserting themselves in Latin America, with diverse creative energy and an embrace of indigenous cul…
There is no evidence that Facebook’s worldwide popularity is linked to widespread psychological harm, according to… https://t.co/wS1Um3JRS5
Related Articles
The world's leading job site for research and insight
Resources Group
Associate Research Director – Focus on Ad hoc studies! – Innovative Insight Consultancy
£45,000–£55,000 + great benefits
Resources Group
Research Executive – Research Consultancy – Corporate Comms and Strategy
£27,000–£32,000 + Benefits
Spalding Goobey Associates
Senior Research Executive – Quantitative Research – For those looking for something a little differe
£33–37,000 + benefits
Featured company
Town/Country: London
Tel: +44 (0)20 7490 7888
Kudos Research is the leading provider of premium quality UK and International Telephone Data-Collection. Specialising in hard to reach B2B and Consumer audiences, we achieve excellent response rates and provide robust, actionable, verbatim-rich data. Methodologies include . . .
Brought to you by:
©2024 The Market Research Society,
15 Northburgh Street, London EC1V 0JR
Tel: +44 (0)20 7490 4911
info@mrs.org.uk
The post-demographic consumerism trend means segments such age are often outdated, from @trendwatching #TrendSemLON
0 Comments